Cue Biopharma, Inc. (CUE) News

Latest headlines that mention CUE, newest first · each headline opens the original publisher

CUE quote

Last price: $20.63
Day change: +10.14%
Next earnings: 2026-11-11

Quote & chart Expected move Insider trading IV rank history

CUE headlines

latest coverage

Investing.com 25d ago

Cue Biopharma CEO Lin Shao-Lee sells $305,490 in shares

General T3CUE

Investing.com 25d ago

Cue Biopharma’s chief legal officer sells $51,724 in stock

General T3CUE

Investing.com 25d ago

Cue Biopharma VP Meluzio sells $32,089 in Cue stock for tax

General T3CUE

Seeking Alpha News 1mo ago

Cue Biopharma, Inc. (CUE) Discusses Positive Phase II Top Line Results for CUE-221 in Chronic Spontaneous Urticaria - Slideshow

General T2CUE

Seeking Alpha News 1mo ago

Cue Biopharma: Initiating 'Buy' Based On CUE-221 Trial Win CSU With Novel Dual MOA

General T2CUE

Seeking Alpha 1mo ago

Cue Biopharma plummets on phase 2 data for chronic spontaneous urticaria asset

General T2CUE

Seeking Alpha News 1mo ago

Cue Biopharma, Inc. (CUE) Discusses Positive Phase II Top Line Results for CUE-221 in Chronic Spontaneous Urticaria Transcript

General T2CUE

Yahoo Finance 1mo ago

Cue Biopharma Shares Jump 41.6% Premarket Following Phase 2 Trial Results

General T2CUE

Investing.com 1mo ago

Why is Cue Biopharma stock surging today?

General T3CUE

Investing.com 1mo ago

Cue Biopharma reports positive phase 2 results for CUE-221

General T3CUE

Seeking Alpha 1mo ago

Cue Biopharma is a new Buy at B. Riley on valuation

General T2CUE

Investing.com 1mo ago

Cue Biopharma stock initiated at Buy by B.Riley on allergy drug potential

General T3CUE

Investing.com 2mo ago

Cue Biopharma legal chief sells $265,627 in common stock

General T3CUE

Investing.com 2mo ago

Cue Biopharma VP Michael Meluzio disposes of $169,323 in stock

General T3CUE

Seeking Alpha 2mo ago

Cue Biopharma GAAP EPS of -$24.14 misses by $22.23, revenue of $7.88M beats by $5.78M

Earnings T2CUE

Seeking Alpha 3mo ago

Cue Biopharma names Dominic Borie as CMO and head of R&D

General T2CUE

Investing.com 4mo ago

Form 4 Cue Biopharma For: 10 July

General T3CUE

Seeking Alpha 4mo ago

Cue Biopharma to raise $50M in oversubscribed private placement

General T2CUE

Investing.com 4mo ago

Cue Biopharma raises $50M in private placement

General T3CUE

Investing.com 5mo ago

Cue Biopharma reports Q1 loss, secures $30M financing

General T3CUE

CUE news alerts

Get an alert by email or push when a new headline mentions CUE.

More news

News headlines aggregated from third-party publishers via public RSS feeds and tagged with the tickers they mention. Frenzy Capital does not publish or endorse the content; clicking a headline opens the original publisher in a new tab.